Following yesterday 15.63% move VRAL pulling back…Stock poised to explode.
Take a fresh look at our July 6, 2010 Profile Report!!!
“VRAL’s Compelling IP including Metabolic Disruption Technology could be transformational with potential applications in multiple disease fronts”
“If you have a strong risk tolerance and looking to build a position in this name this could be a $.20 by year end and as specific milestones along the road to commercialization with the ultimate goal of hitting the jackpot and having one of technologies licensed by a major Pharmaceutical company the stock has the potential to explode by 10-50 folds from current levels.”
July 6, 2010 Profile Report:
Please read our disclaimer carefully and do due diligence before you invest (see link below):